ORCID 0000-0001-8736-3979   ResearcherID V-8119-2017   SCOPUS ID 23490379500

WORK ADDRESS
National Research Ogarev Mordovia State University
430005, Mordovia, Saransk, 68 Bolshevistskaya St.
Phone: +7 (8342) 351310
E-mail: alek-s13@mail.ru

ACADEMIC QUALIFICATION
Doctor of Medical Sciences, Professor

PRESENT POSITION
Professor at the Department of Pharmacology and Clinical Pharmacology with the course of Pharmaceutical Technology, National Research Ogarev Mordovia State University

RESEARCH INTERESTS
Oncopharmacology, increase in efficiency and decrease in toxicity of antitumor chemotherapy

TRAINING OF HIGHLY QUALIFIED PERSONNEL
Five Candidates of Sciences

MEMBERSHIP IN PROFESSIONAL SOCIETIES
Member of the Dissertation Council D 212.117.15, National Research Ogarev Mordovia State University

MEMBERSHIP IN PROFESSIONAL SOCIETIES
Russian medical society of anatomists, histologists and embryologists

MEMBERSHIP IN EDITORIAL BOARDS OF INTERNATIONAL JOURNALS
2012 – present, editorial board member of the “PSU bulletin” journal
2006 – present, editorial board member of the “Astra-khan medical journal”
2007 – present, deputy editor-in-chief of the “Univer-sity proceedings. Volga region. Medical sciences” journal
2002 – 2006 – editorial board member of the “Univer-sity proceedings. Volga region” journal

TOTAL NUMBER OF PUBLICATIONS: Over 90

MAIN PUBLICATIONS
1. Siprov A.V., Kostina Yu.A. Cardioprotective efficiency study of combination of pyrimidine and 3-hydroxypyridine derivatives in experimental antitumor chemotherapy. Saratov Journal of Medical Scientific Research, 2014, vol.10, no. 2, pp. 257-261
2. Siprov A.V., Kostina Yu.A. Comparative estimation of lipid peroxidation and glutathione system changes in liver tissues of rats with Walker-256 carcinoma as a result of using pyrimidine and 3-hydroxypyridine derivatives with doxorubicin and paclitaxel. University proceedings. Volga region. Medical sciences, 2014, no.3 (31), pp. 30-38
3. Siprov A.V., Masyagin V.A. Myeloprotective efficiency of combination of pyrimidine and 3-hydroxypyridine derivatives in experimental antineoplastic chemotherapy. Saratov Journal of Medical Scientific Research, 2015, vol.11, no. 3, pp. 258-262
4. Siprov A.V., Masyagin V.A., Makarova M.Yu., Vashurkina I.М. The estimation of xymedon myeloprotective efficiency at the antineoplastic chemotherapy by cyclophosphamide in experiment. Health and Education Millenium, 2016, vol.18, no.1, pp. 316-318
5. Siprova M.V., Volkova N.D., Siprov A.V., Kuznetsova V.A.The effect of pyrimidine and 3-hydroxypyridine derivatives on an antioxidant potential parameters of ovarian tissue in rats with Walker-256 carcinoma at the antitumor chemotherapy in experiment. Health and Education Millenium, 2017, vol. 19, no. 7, pp. 127-130
6. Siprov A.V., Solovyova M.A. Morphofunctional state of erythrocytes in rats with Walker-256 carcinoma at combined use of docetaxel and xymedon. Bulletin of Experimental Biology and Medicine, 2017, vol.164, no.7, pp. 56-60